• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Acquisition of sero-diagnostic markers for epithelial-mesenchymal transition in lung adenocarcinoma

Research Project

Project/Area Number 16K15249
Research Category

Grant-in-Aid for Challenging Exploratory Research

Allocation TypeMulti-year Fund
Research Field Human pathology
Research InstitutionKitasato University

Principal Investigator

TSUCHIYA BENIO  北里大学, 医療衛生学部, 准教授 (80286385)

Project Period (FY) 2016-04-01 – 2019-03-31
Project Status Completed (Fiscal Year 2018)
Budget Amount *help
¥3,640,000 (Direct Cost: ¥2,800,000、Indirect Cost: ¥840,000)
Fiscal Year 2018: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2017: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2016: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Keywords肺腺癌 / 上皮-間葉移行(EMT) / 血清診断マーカー / EMT / セクレトーム解析 / 腫瘍特異的自己抗体 / 病理学 / 癌 / プロテオーム / トランスレーショナルリサーチ
Outline of Final Research Achievements

Epithelial-mesenchymal transition(EMT)is a key process that drives cancer metastasis and drug resistance, and has been reported for the association with poor prognosis in patients with lung adenocarcinoma. Novel sensitive and specific blood-based biomarkers are needed to detect EMT phenotype at an early stage and to individualize treatment strategies. We performed secretome analysis to identify the secreted proteins from EMT induced lung adenocarcinoma cells. Thirty-four secretory proteins including extracellular matrix proteins and cytokines were found to be upregulated in EMT cells. The serum LUM and MIF expression levels were significantly higher in lung adenocarcinoma patients than in healthy controls.
Identification of aberrantly secreted proteins from EMT induced cells might facilitate the development of sero-diagnostic markers for early detection and monitoring therapeutic effectiveness for lung adenocarcinoma.

Academic Significance and Societal Importance of the Research Achievements

癌の治療におけるEMT制御の必要性は広く認識されているものの、EMTを標的とした血清診断マーカーの獲得を目的とした研究は行われておらず、本研究で得られた結果はこの分野の先行研究として役立つものと思われる。外科的切除に加えて適切かつ積極的な追加治療を行う必要のある、早期に再発や転移を起こす可能性の高い患者を選択できれば、肺癌患者の予後改善につながると考える。

Report

(4 results)
  • 2018 Annual Research Report   Final Research Report ( PDF )
  • 2017 Research-status Report
  • 2016 Research-status Report
  • Research Products

    (9 results)

All 2019 2018 2016

All Journal Article (2 results) (of which Int'l Joint Research: 1 results,  Peer Reviewed: 2 results,  Open Access: 2 results) Presentation (7 results)

  • [Journal Article] <b>Clinicopathological and prognostic significance of nuclear UGDH localization in lung adenocar</b><b>cinoma</b>2019

    • Author(s)
      HAGIUDA Daisuke、NAGASHIO Ryo、ICHINOE Masaaki、TSUCHIYA Benio、IGAWA Satoshi、NAOKI Katsuhiko、SATOH Yukitoshi、MURAKUMO Yoshiki、SAEGUSA Makoto、SATO Yuichi
    • Journal Title

      Biomedical Research

      Volume: 40 Issue: 1 Pages: 17-27

    • DOI

      10.2220/biomedres.40.17

    • NAID

      130007602849

    • ISSN
      0388-6107, 1880-313X
    • Year and Date
      2019-02-01
    • Related Report
      2018 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Prognostic significance of S100A16 sub-cellular localization in lung adenocarcinoma2018

    • Author(s)
      Kobayashi Makoto、Nagashio Ryo、Saito Keita、Aguilar-Bonavides Clemente、Ryuge Shinichiro、Katono Ken、Igawa Satoshi、Tsuchiya Benio、Jiang Shi-Xu、Ichinoe Masaaki、Murakumo Yoshiki、Saegusa Makoto、Satoh Yukitoshi、Sato Yuichi
    • Journal Title

      Human Pathology

      Volume: 74 Pages: 148-155

    • DOI

      10.1016/j.humpath.2018.01.001

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Presentation] 肺腺癌における上皮-間葉移行を標的とした血清診断マーカーの獲得2018

    • Author(s)
      土屋紅緒、柳田憲吾、今野亮、小寺義男、高橋博之、佐藤雄一
    • Organizer
      日本病理学会
    • Related Report
      2018 Annual Research Report
  • [Presentation] ショットガン解析により同定された膜たんぱく質の有用性2018

    • Author(s)
      柳田憲吾、土屋紅緒、佐藤雄一 他
    • Organizer
      日本病理学会
    • Related Report
      2018 Annual Research Report
  • [Presentation] 肺腺癌におけるNAP1L1の予後予測マーカーとしての有用性について2018

    • Author(s)
      長塩亮、柳田憲吾、土屋紅緒、佐藤雄一 他
    • Organizer
      日本病理学会
    • Related Report
      2018 Annual Research Report
  • [Presentation] 肺腺癌におけるCD239の血清診断マーカーとしての有用性2018

    • Author(s)
      柳田憲吾、土屋紅緒、佐藤雄一 他
    • Organizer
      電気泳動学会
    • Related Report
      2018 Annual Research Report
  • [Presentation] 肺腺癌におけるNAP1L1の機能解析2018

    • Author(s)
      長塩亮、柳田憲吾、土屋紅緒、佐藤雄一 他
    • Organizer
      電気泳動学会
    • Related Report
      2018 Annual Research Report
  • [Presentation] 肺腺癌における上皮-間葉移行を標的とした血清診断マーカーの獲得2018

    • Author(s)
      土屋紅緒、栁田憲吾、紺野 亮、小寺義男、高橋博之、佐藤雄一
    • Organizer
      第107回日本病理学会総会
    • Related Report
      2017 Research-status Report
  • [Presentation] 肺腺癌における上皮-間葉移行を標的とした血清診断マーカーの獲得2016

    • Author(s)
      土屋紅緒、蒋世旭、長塩亮、佐藤雄一
    • Organizer
      第105回日本病理学会総会
    • Place of Presentation
      仙台国際センター
    • Year and Date
      2016-05-12
    • Related Report
      2016 Research-status Report

URL: 

Published: 2016-04-21   Modified: 2020-03-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi